Status: Not yet recruiting
A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma
A single-arm, prospective phase II clinical study of neoadjuvant PD-1/CTLA-4 combination antibody with low-dose radiotherapy in resectable dMMR/MSI-H esophagogastric junction/gastric adenocarcinoma.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Jiangsu Cancer Institute & HospitalUpdated: Jul 8, 2025
Eligibility criteria
Patients voluntarily participate in this study, sign the informed consent form,... [+13]
History of surgery for gastric or gastroesophageal junction tumor; [+22]